A pharmacist holds a package of EpiPens, made by the pharmaceutical company Mylan. CEO Heather Bresch will testify before the House Oversight and Government Reform Committee in the coming days after Mylan jacked up the price for the lifesaving drug by more than 500 percent since 2007.
A pharmacist holds a package of EpiPens, made by the pharmaceutical company Mylan. CEO Heather Bresch will testify before the House Oversight and Government Reform Committee in the coming days after Mylan jacked up the price for the lifesaving drug by more than 500 percent since 2007. Rich Pedroncelli The Associated Press
A pharmacist holds a package of EpiPens, made by the pharmaceutical company Mylan. CEO Heather Bresch will testify before the House Oversight and Government Reform Committee in the coming days after Mylan jacked up the price for the lifesaving drug by more than 500 percent since 2007. Rich Pedroncelli The Associated Press

Drug pricing is too complex to fix with Prop. 61

September 17, 2016 08:00 AM

UPDATED September 18, 2016 07:56 PM

Comments

More Videos

  • Trump's FBI pick wants to lead independent bureau that will "make every American proud"

    Christopher A. Wray stated that his "loyalty was to the constitution" and the law during his testimony at the nomination hearing for FBI director on Wednesday. He was grilled by senators on his ability to remain independent of the White House in investiga